06 Feb 2025 10:56 CET

Today, 6 February 2025, a total of 11,259 shares in DNB Bank ASA were acquired
on behalf of certain of DNB's primary insiders, who are part of the Group
Management team. The share purchase was executed collectively at an average
price per share of NOK 247.1206.

The shares were purchased in accordance with the share programme that was
approved by the Annual General Meeting on 30 June 2020. Shares that are acquired
through the programme have a holding period which lasts for as long as the
person holding the shares is part of the Group Management team. Upon leaving the
Group Management team, the shares are released in stages over a period of three
years.

A list of the primary insiders of DNB Bank ASA who have increased their
shareholding is attached.

This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.


637858_DNB_primary_insider_notification.pdf

Source

DNB Bank ASA

Provider

Oslo Børs Newspoint

Company Name

ADJ Sparebank Kreditt 85/25 CALL, ADJ Sparebank Kreditt 86/26, DNB Bank ASA 20/30 FRN C SUB, DNB BANK ASA, DNB Bank ASA 21/29 ADJ C, DNB Bank ASA 21/29 FRN C, DNB Bank ASA 21/32 FRN C SUB, DNB Bank ASA 21/32 ADJ C SUB, DNB Bank ASA 22/32 FRN C SUB, DNB Bank ASA 22/PERP FRN C HYBRID, DNB Bank ASA 22/PERP ADJ C HYBRID, DNB Bank ASA 23/PERP FRN C HYBRID, DNB Bank ASA 23/33 FRN SEK C SUB, DNB Bank ASA 23/33 ADJ C SUB, DNB Bank ASA 23/33 FRN C SUB, DNB Bank ASA 23/33 ADJ SEK C SUB, DNB Bank ASA 23/PERP FRN SEK C HYBRID, DNB Bank ASA 23/PERP ADJ SEK C HYBRID, DNB Bank ASA 23/PERP ADJ C HYBRID, DNB Bank ASA 24/PERP ADJ SEK C HYBRID, DNB Bank ASA 24/30 FRN C

ISIN

NO0001595557, NO0001595599, NO0010883341, NO0010161896, NO0011038309, NO0011038317, NO0011151672, NO0011151680, NO0011203374, NO0012618984, NO0012618992, NO0012740119, NO0012740101, NO0012811829, NO0012850629, NO0012850611, NO0012850603, NO0012850637, NO0013013896, NO0013013904, NO0013013888, NO0013013870, NO0013167114, NO0013223586

Symbol

DNB

Market

Euronext Oslo Børs